
Higher county-level rates of prostate-specific antigen (PSA) screening are associated with lower incidence of advanced/metastatic prostate cancer and lower prostate cancer mortality in subsequent years.


coremsg

A recent analysis found that US counties with higher rates of PSA screening had lower rates of metastatic prostate cancer and prostate cancer mortality in subsequent years.

US County-Level Study Shows Benefits of PSA Screening

us-county-level-study-finds-lower-rates-of-advanced-prostate-cancer-and-mortality-in-areas-with-higher-psa-screening


US County-Level Study Finds Lower Rates of Advanced Prostate Cancer and Mortality in Areas with Higher PSA Screening
